Researchers at ETH Zurich and ETH spin-off Inositec have developed a new substance that is effective to control vascular calcification, which affects many patients suffering from fatal cardiovascular diseases. Vascular Calcification usually occurs when calcium phosphate crystals get stored in tissue. The new substance is associated with inositol hexakisphosphate, also known as IP6, which is usually found in fruits and cereals. Researchers have also made some modifications to make P6 more stable. The ETH scientists will continue on the further development  to overcome various challenges, such as drug safety and the optimal dosage.